Three individuals were admitted to the hospital (ages 46–56; to men and one woman) with a multiday history of symptoms associated with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and underwent contrast-enhanced thoracic CT due to worsening symptomatology. Three-dimensional (3D) digital models were created to visualise the extent of the disease within the respiratory system (figures 1 and 2) from the thin section (1 mm) data sets. All patients presented emergently with variable pulmonary symptoms ranging from mild to severe, including shortness of breath and all were febrile. Two of the patients were reverse transcription polymerase chain reaction (RT-PCR) positive for SARS-CoV-2 (figure 1B,D,F; figure 2C,D,G,H). The third patient was RT-PCR negative for SARS-CoV-2, but this was presumed to be a false-negative result given compelling clinical and imaging features indicative of COVID-19 (figures 1C,E and 2E,F). A fourth patient who presented to the emergency department and was suspected of having COVID-19 also underwent CT to assess for the possibility of pulmonary embolus (figures 1A and 2A,B). This individual tested negative for SARS-CoV-2, and the lungs were normal. All CT examinations were obtained using a Philips iCT 256 or iQon Spectral CT systems. Data were acquired using a 128×0.625 mm or 64×0.625 mm detector configuration with dual sampling, rotation time of 0.33 s (120 kVp 72 mAs).
Three-dimensional segmented surface models of normal, COVID-19 and suspected COVID-19 lungs in anterior view. (A) Healthy lung model of a 50-year-old man. (B) Lung model of a COVID-19-positive 46-year-old man with mild respiratory symptoms. (C) Lung model of a COVID-19-negative 56-year-old man with clinical suspicion for COVID-19. (D) Lung model of a COVID-19-positive 55-year-old woman with severe respiratory symptoms and ARDS. (E) C with a skeleton. (F) D but with the ARDS tissue made translucent to demonstrate the full extent of the ground glass opacities and consolidation throughout the parenchyma. ARDS, acute respiratory distress syndrome; C, consolidated infection; GGO, ground-glass opacities; HP, healthy parenchyma; PB, primary bronchus; TR, trachea. Colour key: blue, healthy tissue; yellow, consolidation and ground glass opacities; green, ARDS.
Three-dimensional (3D) segmented surface models of normal, COVID-19 and suspected COVID-19 lungs in posterior view (left) and coronal views with accompanying simplified diagrammatic illustrations of the coronal CTs demonstrating the infection sites. Healthy lungs of a 50-year-old man as a segmented 3D model in posterior view (A), a coronal contrast enhanced CT slice (B) and a diagrammatic illustration of B (C). COVID-19-positive 46-year-old man (mild respiratory symptoms) as a segmented 3D model in posterior view (D), a coronal contrast enhanced CT slice (E) and a diagrammatic illustration of E (F). Lungs of a COVID-19-negative 56-year-old man with clinical suspicion for COVID-19 as a segmented 3D model in posterior view (G), a coronal contrast-enhanced CT slice (H) and a diagrammatic illustration of H (I). Lungs of a COVID-19-positive 55-year-old woman with ARDS as a segmented 3D model in posterior view (J), a coronal contrast enhanced CT slice (K) and a diagrammatic illustration of K (L). Models demonstrate the relationship, distribution and full extent of the disease in 3D versus the single CT slice which only provides information on the localised position of the infection. ARDS, acute respiratory distress syndrome; C, consolidated infection; GGO, ground-glass opacities; HP, healthy parenchyma. Colour key: blue, healthy tissue; yellow, consolidation and ground glass opacities; green, ARDS. Images not to (relative) scale.
Image Credit: BMJ
News This Week
Experts have discovered what they believe is the world’s most mutated COVID strain – and there’s one detail in particular that has scientists worried. Scientists have detected what is believed to be the world’s [...]
SARS-CoV-2, the virus that causes COVID-19, likely does not directly infect the brain but can still inflict significant neurological damage, according to a new study from neuropathologists, neurologists, and neuroradiologists at Columbia University Vagelos [...]
ANSTO has contributed to a comprehensive investigation of a promising type of nanoparticle that could potentially be used for intractable brain cancers in a combined therapy. The study, which was led by Dr. Moeava [...]
The immune response needed to protect people against reinfection with the coronavirus will be explored in a new human challenge trial, researchers have revealed. Human challenge trials involve deliberately exposing healthy people to a [...]
Researchers from Duke University are developing a flu shot with the new technology that was used for two coronavirus vaccines. Both the Pfizer-BioNTech and the Moderna shots use part of the virus's genetic code [...]
Researchers from the University of Liverpool have shown the potential of repurposing an existing and cheap drug into a long-acting injectable therapy that could be used to treat Covid-19. In a paper published in the journal Nanoscale, [...]
Researchers have developed a new superbug-destroying coating that could be used on wound dressings and implants to prevent and treat potentially deadly bacterial and fungal infections. The material is one of the thinnest antimicrobial [...]
The U.S. is recommending a "pause" in administration of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots. In a joint statement Tuesday, the Centers for Disease Control [...]
The South African coronavirus variant is better at "breaking through" the defences of the Pfizer/BioNTech vaccine than other forms of the virus, Israeli experts said Sunday. However, one of the authors told AFP that [...]
EPFL scientists have developed AI-powered nanosensors that let researchers track various kinds of biological molecules without disturbing them. The tiny world of biomolecules is rich in fascinating interactions between a plethora of different agents [...]
A team of researchers from the Institute for Infectious Diseases (IFIK) at the University of Bern and the Federal Institute of Virology and Immunology (IVI) have assessed virus growth and activation of the cellular [...]
Researchers at Brown University have succeeded in creating the first wireless, implantable, rechargeable, long-term brain-computer interface. The wireless BCIs have been implanted in pigs and monkeys for over 13 months without issue, and human [...]
The coronavirus outbreak made household names of companies like Moderna Inc. and BioNTech SE, whose shots offered hope for ending the pandemic. Now a new wave of vaccines is on the horizon that may get the [...]
Researchers at the University of Southampton have developed a new way of using nanomaterials to identify and enrich skeletal stem cells—a discovery which could eventually lead to new treatments for major bone fractures and [...]
In March 2020, Hannu Rajaniemi pivoted his biotech company Helix Nanotechnologies' focus from cancer therapies to Covid-19 vaccines. The role biotech start-ups can play in a pandemic Rajaniemi originally co-founded Helix Nanotechnologies in Cambridge, Massachusetts in [...]
The rapid mass testing strategy costing just £1 a day per child can get children back to school and economies up and running, according to experts. That is the small price of the [...]